NuScale Power Is Now Down 49% This Year: Is SMR Stock Dead Money or Due for a Bounce?

NuScale Power shares are down 49% year to date at $7.18, while the S&P 500 is up 14%; the company reported quarterly revenue of just $75,000 after prior-year engineering work ended. NuScale filed in August to sell up to $750 million in additional shares through an at-the-market offering, intensifying dilution concerns as commercial reactor deployment is not expected until the early 2030s. Investors are watching for new engineering and licensing revenue and updates on how much of the offering has been used.

Analysis

NuScale’s key risk is not simply weak quarterly revenue; it is the financing loop: uncertain project timing can delay billable work, while continued development spending may require equity before commercial revenue arrives. An authorized ATM is not the same as completed issuance, so the immediate overhang depends on actual shares sold, cash burn and remaining liquidity—not the headline capacity alone.

Near term (days to weeks), expect financing updates and contract announcements to dominate any “oversold” argument. Over 1–3 months, the decisive evidence is whether new engineering/licensing awards convert into recognized revenue and whether cash consumption forces faster issuance. Over 6–18 months, credible customer commitments and licensing progress could improve financing terms; setbacks could raise the cost of capital across pre-revenue reactor developers, including Oklo, even absent company-specific news.

Contrarian point: the relative resilience of uranium exposure does not establish a floor for reactor developers. Fuel demand and long-dated reactor project economics are different exposures. Conversely, a successful, funded contract could trigger a sharp sentiment rebound from depressed expectations; price weakness alone does not prove dilution is fully priced.

Key Decisions for Investors

• Do not buy SMR solely on the year-to-date decline. Wait for disclosure of ATM utilization, cash runway and new contracted work; treat unquantified pipeline announcements as insufficient confirmation.
• Conditional relative-value idea: a small, risk-controlled short SMR / long LEU position expresses a preference for current fuel-related revenue over long-duration developer financing risk. It is not a clean hedge: LEU has separate fuel-market and company risks. Reassess on contract, issuance and fuel-market news; exit the thesis if SMR converts funded awards into recurring revenue or LEU’s operating outlook deteriorates.
• Avoid treating URA as a direct hedge for SMR. Track whether developer shares begin outperforming fuel equities alongside independently verifiable contract awards; narrowing performance gaps without improved fundamentals would be a weak bounce signal.
• Falsifiers: a material acceleration in SMR share issuance or worsening cash burn supports the downside case; demonstrable revenue conversion, funded customer commitments and slower-than-feared dilution would undermine it. Verify reported share sales and backlog conversion before sizing any position.